Analyst ratings, especially from reputable financial institutions like Citigroup, can significantly influence investor sentiment and stock prices. The initiation of coverage with a Buy rating and a relatively high price target suggests a positive outlook for Solid Biosciences, which could lead to increased investor interest and a potential rise in SLDB's stock price in the short term.